Genetically modified bone marrow cells halt mitral cell loss by modulating inflammation and protecting against DNA damage

Cell therapy is a promising strategy for tackling neurodegenerative diseases. The most outstanding results with this approach usually involve neuroprotection of damaged neurons at risk of death, but only with limited success. Current therapies are often based on the idea of “one gene, one disease, o...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	David Díaz, Eva María Baranda-Alonso, Laura Pérez-Revuelta, Juan Felipe Zapata-Acevedo, Frédéric Torossian, Adrienne Anginot, José Ramón Alonso, Marie-Caroline Le Bousse-Kerdilès, Eduardo Weruaga
Format:	Artigo
Język:	Inglês
Wydane:	SAGE Publishing 2026-05-01
Seria:	Journal of Tissue Engineering
Dostęp online:	https://doi.org/10.1177/20417314261442787
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!